Latest Biguanides Stories
A recently-published literature review reveals that people with prediabetes have a 15 percent higher risk of developing cancer — and the level of risk differs depending on the type of cancer.
In Phase 3 studies, INVOKANA® plus metformin lowered blood sugar and reduced secondary endpoints of body weight and systolic blood pressure to a greater degree than metformin alone RARITAN,
- Combination of linagliptin and metformin significantly reduced blood glucose levels compared with linagliptin alone RIDGEFIELD, Conn. and INDIANAPOLIS, Aug.
- Recent Publication Shows Metformin Improves Glycemic Control by Modulating the Gut Microbiome and Triggering Specific Cellular and Immune Mechanisms - BROOMFIELD, Colo., June
ROCKVILLE, Md., June 10, 2014 /PRNewswire-USNewswire/ -- Patients with type 2 diabetes who take a combination of metformin plus insulin may be at higher risk for cardiovascular disease and death
In a new study, the type 2 diabetes drug metformin was found to have different effects on the hearts of men and women, despite managing blood sugar the same in both sexes.
A new study published online in The Oncologist journal shows that cancer patients with concurrent type 2 diabetes treated with metformin have a greater overall survival rate compared with patients
- A poem in which the author retracts something said in an earlier poem.